Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-25-011863
Filing Date
2025-02-12
Accepted
2025-02-12 08:30:17
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 16027
  Complete submission text file 0001104659-25-011863.txt   17914
Mailing Address 5956 SHERRY LANE SUITE 1365 DALLAS TX 75225
Business Address 5956 SHERRY LANE SUITE 1365 DALLAS TX 75225 214-468-0008
Prosight Management, LP (Filed by) CIK: 0001617201 (see all company filings)

EIN.: 263706721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Subject) CIK: 0001796129 (see all company filings)

EIN.: 833197402 | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-91457 | Film No.: 25612130
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)